Cargando…

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction

Background and objectives: No-reflow (NR) phenomenon is defined as insufficient myocardial perfusion in coronary circulation in the absence of angiographic evidence of mechanical obstruction. The primary mechanisms of the NR occurrence are thought to be high platelet activity and thrombus burden. So...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tascanov, Mustafa Begenc, Tanriverdi, Zulkif, Gungoren, Fatih, Besli, Feyzullah, Erkus, Muslihittin Emre, Gonel, Ataman, Koyuncu, Ismail, Demirbag, Recep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681218/ https://www.ncbi.nlm.nih.gov/pubmed/31311177 http://dx.doi.org/10.3390/medicina55070376

Ejemplares similares

Comparisons of microbiota-generated metabolites in patients with young and elderly acute coronary syndrome
por: Taşcanov, Mustafa Beğenç, et al.
Publicado: (2020)

Unusual complication of carotid artery stenting as the result of a proximal emboli protection device (the Mo.Ma): Iatrogenic common carotid artery dissection
por: Güngören, Fatih, et al.
Publicado: (2019)

The relationship between myocardial bridge and frontal QRS‐T angle
por: Tascanov, Mustafa Begenc, et al.
Publicado: (2022)

High aortic pulse-wave velocity may be responsible for elevated red blood cell distribution width in overweight and obese people: a community-based, cross-sectional study
por: Altiparmak, Ibrahim Halil, et al.
Publicado: (2016)

SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients
por: Toprak, Kenan, et al.
Publicado: (2022)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

The Protective Effect of Naringenin-Oxime on Cisplatin-Induced Toxicity in Rats
por: Koyuncu, Ismail, et al.
Publicado: (2017)

The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction
por: Bolayır, Hasan Ata, et al.
Publicado: (2017)

Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells
por: Koyuncu, Ismail, et al.
Publicado: (2018)

Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line
por: Koyuncu, Ismail, et al.
Publicado: (2018)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

The No-reflow Phenomenon: Is it Predictable by Demographic factors and Routine Laboratory Data?
por: Namazi, Mohammadhasan, et al.
Publicado: (2021)

Investigation of the effect of vitamin K1 prophylaxis on newborn screenings tests in newborns
por: Caglayan, Murat, et al.
Publicado: (2023)

Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction
por: Li, Junxia, et al.
Publicado: (2015)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2022)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Mean platelet volume is not associated with coronary slow flow: A retrospective cohort study
por: Kaya, Zekeriya, et al.
Publicado: (2015)

Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells
por: Temiz, Ebru, et al.
Publicado: (2021)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes
por: Kaul, Sanjiv, et al.
Publicado: (2022)

Relationship Between Tei Index and PEP-Derived Myocardial Performance Index in Sinus Rhythm
por: Besli, Feyzullah, et al.
Publicado: (2015)

An Investigation of Oxidative Stress and Thiol/Disulphide Homeostasis in Graves’ Disease
por: Agan, Veysel, et al.
Publicado: (2019)

Efficacy of combination of N-acetylcysteine and primrose in spinal cord injury; an experimental study
por: Çavuş, Umut Yücel, et al.
Publicado: (2023)

No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications
por: Ahn, Seong Joon, et al.
Publicado: (2015)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction()
por: Katayama, Yosuke, et al.
Publicado: (2022)

A new predictor for indicating clinical severity and prognosis in COVID-19 patients: Frontal QRS-T angle
por: Ocak, Metin, et al.
Publicado: (2021)

Predictive efficacy of frontal QRS-T angle in COVID-19 patients
por: Ocak, Metin, et al.
Publicado: (2022)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Delayed Treatment With Hypothermia Protects Against the No‐Reflow Phenomenon Despite Failure to Reduce Infarct Size
por: Hale, Sharon L., et al.
Publicado: (2013)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2015)

hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention
por: Liu, Min, et al.
Publicado: (2017)

Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts
por: Hashemi-Jazi, Mohammad, et al.
Publicado: (2017)

No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
por: Buono, Andrea, et al.
Publicado: (2019)

Calcified plaque harboring lipidic materials associates with no-reflow phenomenon after PCI in stable CAD
por: Hosoda, Hayato, et al.
Publicado: (2023)

Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0iiji58rq3aeoesisnaj5kr51i